Please assess the completion status of the following clinical trial:

Trial Title: Feeding Intervention for Infants With Crying

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* full term infants greater than or equal to 37 wks gestation~* 3 weeks to less than or equal to 4 months of age upon enrollment~* experiencing ongoing crying and fussy episodes of a minimum of 3 hours of crying /day for 3 days in a week for at least one week prior to enrollment~* otherwise healthy as reported by parent/caregiver~* is under the care of a pediatrician or other qualified healthcare professional and has had at least one postnatal visit~* taking no more than one feeding of breast milk per day~* having not initiated weaning foods or beverages other than infant formula or breast milk~* study explained and written information provided with Parent/caregiver demonstrating understanding of the given information~* informed consent signed(parent/legal representative)~Exclusion Criteria:~* Chromosomal or major congenital anomalies~* known cow's milk allergy~* receiving any type of therapeutic formula (including extensively hydrolyzed formula or free amino acid formula)~* receiving an antibiotic or probiotic in the week prior to enrollment~* complicated reflux, defined by reflux combined with inadequate growth and/or respiratory complications~* infant's family, who in the investigator's assessment, cannot be expected to comply with the protocol~* infant currently participating in another conflicting clinical study

- Gender: ALL
- Minimum Age: 3 Weeks
- Maximum Age: 4 Months
- Healthy Volunteers: t

Study Arms:
- Infant formula with probiotic (Type: EXPERIMENTAL): Infant formula with probiotic for 0 to 12 months of age
- Standard infant formula (Type: PLACEBO_COMPARATOR): Infant formula for 0 to 12 months of age

Based on this trial design, predict the completion outcome and termination type (if applicable).